Stock listing
NASDAQ:IMVT Immunovant, Inc. Stock
Home listing (NASDAQ) of Immunovant, Inc.
Follow Immunovant, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IMVT
$29.17 USD -0.47 (-1.6%)
Close on Oct 30, 2026
- Day range
- $28.76 – $29.78 USDOct 30, 2026
- Volume
- 1.17M sharesOct 30, 2026
- Market cap
- $6.03B USDAt the close on Oct 30, 2026 · price × 206.6M shares outstanding
- 52-week range
- $21.43 – $45.42 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $47.73M USDMedian day 1.24M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IMVT · Home | $29.17 USD | -0.47 (-1.6%) | 1,165,416 | $29.49 | $29.78 | $28.76 | $29.64 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IMVT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $29.17 | -0.47 | -1.6% | $29.49 | $29.78 | $28.76 | 1,165,416 | |
| $29.64 | +0.22 | +0.7% | $29.56 | $30.07 | $29.33 | 1,399,285 | |
| $29.42 | +0.54 | +1.9% | $28.50 | $29.47 | $28.44 | 1,241,925 | |
| $28.88 | +0.71 | +2.5% | $28.06 | $28.96 | $28.01 | 1,057,999 | |
| $28.17 | -0.24 | -0.8% | $28.46 | $28.50 | $27.63 | 1,195,295 | |
| $28.41 | -0.69 | -2.4% | $28.93 | $28.93 | $28.14 | 641,437 | |
| $29.10 | +0.72 | +2.5% | $28.09 | $29.12 | $27.98 | 1,157,318 | |
| $28.38 | -0.21 | -0.7% | $28.97 | $29.18 | $28.05 | 1,494,805 | |
| $28.59 | +0.97 | +3.5% | $27.76 | $29.14 | $27.62 | 1,448,985 | |
| $27.62 | +0.89 | +3.3% | $27.12 | $27.84 | $26.53 | 1,375,274 | |
| $26.73 | -0.78 | -2.8% | $27.42 | $27.42 | $26.28 | 1,463,200 | |
| $27.51 | -0.39 | -1.4% | $28.03 | $28.33 | $27.48 | 1,649,300 | |
| $27.90 | -0.81 | -2.8% | $28.46 | $28.79 | $27.83 | 1,773,500 | |
| $28.71 | -0.77 | -2.6% | $29.37 | $29.64 | $28.70 | 1,242,700 | |
| $29.48 | -0.99 | -3.2% | $30.17 | $30.60 | $28.61 | 2,241,900 | |
| $30.47 | +0.21 | +0.7% | $30.25 | $30.64 | $30.07 | 1,494,800 | |
| $30.26 | -1.78 | -5.6% | $31.40 | $31.50 | $29.80 | 1,755,400 | |
| $32.04 | -0.07 | -0.2% | $31.72 | $32.75 | $31.58 | 1,131,400 | |
| $32.11 | -1.14 | -3.4% | $33.51 | $33.51 | $31.36 | 1,674,000 | |
| $33.25 | -0.37 | -1.1% | $33.99 | $33.99 | $32.95 | 1,103,200 | |
| $33.62 | -0.03 | -0.1% | $34.11 | $34.24 | $33.21 | 1,022,200 | |
| $33.65 | -0.13 | -0.4% | $33.56 | $34.60 | $33.30 | 1,671,800 | |
| $33.78 | +0.32 | +1.0% | $33.62 | $34.20 | $33.12 | 1,433,900 | |
| $33.46 | -0.03 | -0.1% | $33.43 | $33.53 | $32.45 | 1,311,400 | |
| $33.49 | +0.19 | +0.6% | $32.93 | $33.77 | $32.65 | 1,229,300 | |
| $33.30 | -0.70 | -2.1% | $34.00 | $34.22 | $33.17 | 2,350,000 | |
| $34.00 | -0.54 | -1.6% | $34.21 | $34.55 | $33.35 | 1,479,300 | |
| $34.54 | -2.75 | -7.4% | $36.35 | $37.00 | $33.60 | 3,652,800 | |
| $37.29 | +0.11 | +0.3% | $37.38 | $38.15 | $36.84 | 2,255,200 | |
| $37.18 | +0.23 | +0.6% | $37.23 | $37.49 | $36.55 | 1,031,400 | |
| $36.95 | -0.70 | -1.9% | $37.52 | $38.35 | $36.80 | 2,943,800 | |
| $37.65 | +1.27 | +3.5% | $37.09 | $37.68 | $36.54 | 1,330,600 | |
| $36.38 | -0.27 | -0.7% | $36.75 | $37.22 | $36.11 | 1,169,200 | |
| $36.65 | -1.01 | -2.7% | $37.43 | $37.50 | $36.19 | 1,573,800 | |
| $37.66 | +0.30 | +0.8% | $37.25 | $38.03 | $37.00 | 1,110,900 | |
| $37.36 | -0.74 | -1.9% | $38.62 | $38.93 | $37.19 | 1,031,900 | |
| $38.10 | -0.65 | -1.7% | $38.18 | $38.31 | $37.53 | 1,083,400 | |
| $38.75 | -0.82 | -2.1% | $39.11 | $39.73 | $38.67 | 1,023,700 | |
| $39.57 | +0.32 | +0.8% | $38.59 | $40.56 | $38.34 | 1,513,700 | |
| $39.25 | +0.13 | +0.3% | $39.44 | $39.73 | $38.73 | 765,600 | |
| $39.12 | -0.37 | -0.9% | $39.48 | $39.48 | $38.64 | 1,235,400 | |
| $39.49 | -0.41 | -1.0% | $40.15 | $40.96 | $38.61 | 1,331,000 | |
| $39.90 | -0.92 | -2.3% | $40.60 | $41.37 | $39.20 | 1,585,500 | |
| $40.82 | -0.38 | -0.9% | $40.96 | $41.28 | $39.91 | 1,391,700 | |
| $41.20 | -2.62 | -6.0% | $43.27 | $43.38 | $41.09 | 1,082,500 | |
| $43.82 | -0.07 | -0.2% | $43.60 | $43.95 | $43.14 | 868,500 | |
| $43.89 | +0.39 | +0.9% | $43.54 | $44.21 | $42.65 | 852,400 | |
| $43.50 | +0.18 | +0.4% | $43.79 | $44.50 | $43.27 | 1,346,827 | |
| $43.32 | -1.05 | -2.4% | $44.00 | $44.04 | $43.20 | 1,189,318 | |
| $44.37 | +0.02 | 0.0% | $44.85 | $45.12 | $44.08 | 846,600 | |
| $44.35 | -0.61 | -1.4% | $44.37 | $44.69 | $43.42 | 954,400 | |
| $44.96 | +0.66 | +1.5% | $45.27 | $45.42 | $44.11 | 1,273,500 | |
| $44.30 | +0.59 | +1.3% | $42.95 | $44.38 | $42.64 | 1,544,300 | |
| $43.71 | +1.89 | +4.5% | $41.72 | $43.89 | $41.46 | 1,216,500 | |
| $41.82 | 0.00 | 0.0% | $42.16 | $42.16 | $40.82 | 722,500 | |
| $41.82 | -0.78 | -1.8% | $42.92 | $42.92 | $41.63 | 1,361,000 | |
| $42.60 | +1.67 | +4.1% | $40.92 | $42.62 | $40.71 | 2,002,300 | |
| $40.93 | +1.04 | +2.6% | $39.66 | $40.93 | $38.99 | 1,138,900 | |
| $39.89 | -0.06 | -0.2% | $39.95 | $40.00 | $39.13 | 1,193,500 | |
| $39.95 | +0.21 | +0.5% | $39.86 | $40.33 | $38.95 | 906,200 | |
| $39.74 | +0.46 | +1.2% | $37.98 | $39.85 | $37.98 | 918,000 | |
| $39.28 | -0.08 | -0.2% | $39.73 | $39.98 | $38.72 | 1,522,300 | |
| $39.36 | +0.85 | +2.2% | $39.13 | $39.76 | $38.80 | 990,700 | |
| $38.51 | -0.11 | -0.3% | $38.28 | $38.87 | $36.78 | 704,200 | |
| $38.62 | -0.86 | -2.2% | $39.31 | $39.32 | $38.00 | 669,700 | |
| $39.48 | +0.87 | +2.3% | $38.61 | $39.80 | $38.47 | 668,100 |
- Ticker
- NASDAQ:IMVT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Latest earnings call · Aug 6, 2026
Immunovant (NASDAQ:IMVT) Q1 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 62 slides
Calls
Upcoming
Immunovant (NASDAQ:IMVT) Q2 2026 Earnings Call
Mon, Nov 09, 2026 · 8:00 AM ET
Register
Replays
Immunovant (NASDAQ:IMVT) Q1 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptImmunovant (NASDAQ:IMVT) Q3 2025 Earnings Call
Fri, Feb 06, 2026 · 8:00 AM ET
Watch TranscriptImmunovant (NASDAQ:IMVT) Q2 2025 Earnings Call
Mon, Nov 10, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Oct 21, 2026
Closed $28.38 (-0.7%) on Oct 21, 2026
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
Sep 23, 2026
Closed $34.54 (-7.4%) on Sep 23, 2026
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Jul 23, 2026
Closed $39.41 (+0.1%) on Jul 24, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
May 20, 2026
Closed $35.56 (+35.3%) on May 20, 2026
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
May 11, 2026
Closed $28.65 (-1.4%) on May 12, 2026
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Apr 2, 2026
Closed $24.50 (-2.4%) on Apr 2, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
Feb 6, 2026
Closed $27.05 (+12.4%) on Feb 6, 2026
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
Jan 23, 2026
Closed $26.60 (+2.3%) on Jan 26, 2026
Immunovant Announces Pricing of $550 Million Common Stock Financing
Dec 11, 2025
Closed $24.81 (+5.3%) on Dec 11, 2025
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
Nov 10, 2025
Closed $23.37 (+0.1%) on Nov 10, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 62 slides · September 2026
Q1 2026 Earnings Presentation
Earnings · 69 slides · Aug 6, 2026
Technical Presentation (September 2025)
Technical · 23 slides · Sep 3, 2025
Corporate Update (April 2025)
Corporate update · 27 slides · Apr 21, 2025
Immunovant, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 89 in all · newest Oct 21, 2026 · oldest 2019
- Calls
- 7 calls with a replay · 7 with a transcript · latest Aug 6, 2026
- Decks
- 29 decks · latest September 2026
Where Immunovant, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IMVT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:IMVT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Immunovant, Inc.